Fox P2 Media LLC publishes a new class of peer reviewed medical publications under the title of The Medical Roundtable (TMR). TMR publishes Expert Roundtable Discussions only; we do not publish review or original articles or case studies.
The Cardiovascular Edition of TMR launched in 2009 at the American Heart Association Scientific Sessions and the General Medicine Edition launched in the Fall of 2012 at the American Academy of Family Practioners Scientific Assembly.
Editorial Policy & Practices
The Medical Roundtable Series’ mission is to publish the clinical guidance, expert opinions, criticisms and to debate compelling topics among expert physicians in an Expert Roundtable Discussion format (ERD). Our mission is based upon 2 of the top 3 most important sources of information for healthcare providers – physicians' peers and peer reviewed medical journals. Physicians learn from and trust the insight and experience of their colleagues. Now the experts have a peer-reviewed forum dedicated to sharing their thoughts and educating their peers.
TMR supports the collaboration of academia, life science companies, physicians and professional societies in bringing quality, clinically relevant information to healthcare professionals. Scientific exchange and debate is critical to maintaining innovation in healthcare. As such, TMR welcomes the submission of topics and roundtables of interest regardless of affiliation. All submitted topics and roundtables are extensively peer-reviewed, vetted and approved by the Editorial Board and the discussants prior to being initiated and/or published.
The Editorial Board members and other engaged experts in the relevant therapeutic field develop the content of the ERD to be discussed. In some instances fees - may be paid by commercial entities that may or may not have an interest in the topic discussed during the ERD. TMR’s policy is that all discussants remain in full and complete editorial control of the concept and content of any ERD at all times and approve the drafts and final version of the article to be published in TMR.
Peer Review Process
All ERDs undergo a rigorous specialist Peer Review Process for fair balance, accuracy, commercialism, and unreasonable bias. The basic criterion for acceptance for publication is that the topic of the ERD described must be clinically relevant, medically and scientifically accurate, demonstrating clarity, balance, objectivity and reasonable subjectivity given the opinion-based nature of the discussion. The Peer Review Process is designed to provide authoritative help and constructive assistance in achieving TMR’s aim to publish quality fair and balanced content rapidly.
The Editorial Board and Publisher shall have the final decision of the content to be published within TMR following the Peer Review Process has been completed.
Conflicts of Interest and Disclosure
TMR supports and follows sound, ethical publishing practice guidelines and initiatives promulgated by such organizations as ICMJE, ISMPP (including GPP), COPE, NLM and others that encourage integrity, transparency and disclosure in medical publishing. In an effort to provide transparency in accordance with and with respect for those recommended by the aforementioned organizations, TMR requires that any person in a position to influence the content of TMR provide a formal statement of relevant conflicts of interest with regard to the topic of the discussion. These relationships shall be made available to our editorial board members, peer-reviewers and disclosed to our readers in print and/or on our web site.
Conflicts of interest can be present in many situations including, personal, political, intellectual, and religious biases. Those conflicts that are most widely recognizable are financial interests relevant to the area of research or discussion. With regard to identifying conflicts of interest, TMR has instituted the following Conflict of Interest and Disclosure policy:
The Medical Roundtable requests each discussant to disclose any potential conflicts of interest, including pertinent financial interests (which may include substantial stock ownership or other ownership interest, or intellectual property rights, where such interests may be valued, or estimated to be, greater than US $10,000 or 5% of the discussant’s personal annual income in the year of publication) in any company or institution that directly benefits from the publication of their portion of the discussion.
Each discussant is sent a request to provide the above information. If any discussant has a perceived conflict of interest beyond financial interests, the Publisher expects each discussant to provide a written statement affirming no conflicts or disclosing relevant conflicts for consideration by and disclosure to the TMR readership.
The purpose of this policy is not to prevent any individual with a conflict of interest from participating in or providing content for TMR, but rather to ensure that the content contained within TMR promotes improvements or quality in therapeutic options in a just and balanced approach, including providing that information to our readers for their consideration. A real or potential conflict of interest will not bar content from consideration for publication by TMR. TMR balances the reality of compensating professional individuals for their time and effort with respect to developing Expert Roundtable Discussions, the academic and clinical excellence of the educations, reputations and achievements of such discussants, with the potential for personal bias through TMR’s Editorial Policy.
Publication and Distribution Fees
TMR’s rapid publication of ERDs is supported through fees charged per roundtable discussion or series thereof. These fees support the expedited transcription, processing, preparation, printing and distribution of expert roundtable discussions as well as online access.
In some instances, fees may be paid by life science companies that may or may not have a conflict of interest related to the topic discussed. In all cases, TMR will publish in print and/or on the web site the related disclosures for our readership’s reference and consideration.
While the primary practice of Publisher is to invite discussants who agree to provide their expertise on a voluntary and financially independent basis, on occasion, additional technical or financial support may be provided or paid to the discussants to facilitate their participation or fairly compensate them for their expertise, time and effort in creation of the ERD – which shall be disclosed by the Publisher.
ERDs are published with the understanding that their copyright is assigned to Publisher in any format, print, electronic, or any other format now known or hereafter discovered, including the right to create audio, ebook, mobile device or other electronic distribution or formatting, once accepted by the Publisher. However, Publisher grants each discussant a license to print and distribute copies of the ERD in furtherance of each discussant’s professional and academic engagements, in an amount not to exceed 50 copies - printed or electronic.
If any material used is subject to third-party copyright, copyright clearance is the sole responsibility of each discussant and must be supplied in writing to the Publisher. Each discussant is sent a copyright acknowledgment and transfer form to complete and execute upon acceptance of the ERD.
Application of Policies
The above policies and processes shall be applied by TMR at all times. Variation from the above policies and processes will be considered on a case-by-case basis by TMR only in emergent situations or special circumstances.